BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Paradigms Foundation
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261029T170000
DTEND;TZID=Europe/Paris:20261029T180000
DTSTAMP:20261008T162216Z
CREATED:20260714T120304Z
LAST-MODIFIED:20261008T162216Z
UID:14577-1793293200-1793296800@paradigms.foundation
SUMMARY:Live Webinar on how healthcare system classification impacts treatment choice in multiple sclerosis
DESCRIPTION:Healthcare systems play a fundamental role in determining how people living with Multiple Sclerosis (MS) access diagnosis\, treatment and long-term specialist care. While scientific advances continue to expand therapeutic options\, differences in healthcare organisation\, reimbursement policies\, drug availability and clinical pathways create substantial variation in patient care across countries. \n\n\n\nIn this expert panel discussion\, Thomas Berger will moderate a conversation with leading European neurologists and Paradigms members to explore how healthcare systems influence the delivery of optimal MS care. Through country-specific perspectives and interactive discussion\, the panel examines practical challenges\, identifies successful approaches\, and considers how healthcare systems can evolve to improve access to high-quality care while making efficient use of available resources. \n\n\n\n\nRegister for the live webinar\n\n\n\n\nLearning Objectives\n\n\n\nFollowing this webinar\, participants should be better able to: \n\n\n\n\nRecognize how differences in healthcare systems\, national guidelines and reimbursement policies can influence MS treatment choices and access to care.\n\n\n\nDiscuss the importance of balancing treatment costs with the broader clinical and societal burden of MS when considering healthcare resource allocation.\n\n\n\nExplore the role of neurologists\, multidisciplinary teams\, registries and real-world data in supporting evidence-based and integrated MS care.\n\n\n\nIdentify key considerations for sustainable access to high-quality MS treatments\, including treatment availability\, quality and continuity of supply.\n\n\n\nConsider opportunities to strengthen patient involvement in treatment decisions\, care delivery and data generation.\n\n\n\n\nWho should attend?\n\n\n\nThis webinar is intended for: \n\n\n\n\nClinically active neurologists\n\n\n\nMultiple Sclerosis specialists\n\n\n\nNeurology residents and trainees\n\n\n\nMS nurses and other healthcare professionals involved in multidisciplinary MS care\n\n\n\n\nThe webinar will be submitted for accreditation to the relevant Belgian authorities. \n\n\n\nRecording\n\n\n\nThe webinar recording is expected to be published on the ParadigMS educational platform following the live session. Access will be restricted to healthcare professionals. \n\n\n\nRegistration\n\n\n\nThis session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions!  \n\n\n\n\nRegister for the live webinar\n\n\n\n\nLanguage\n\n\n\nThe session will be held in English with  \n\n\n\nFind out more about the speakers: \n\n\n\nSpeakers\n\n\n\n\nThomas Berger (AT) (Moderator)\n\n\n\nMelinda Magyari (DK)\n\n\n\nNikolaos Grigoriadis (GR)\n\n\n\nJelena Drulovic (RS)\n\n\n\nMagd Zakaria (EG)\n\n\n\nTjalf Ziemssen (DE)\n\n\n\n\n\n\n\n\n\nThomas Berger\n\n\n\n\nProfessor of Neurology and Chair of the Dept. of Neurology at the Medical University of Vienna  \n\n\n\n\n\n\n\n\n\n\n\n\nMagd Zakaria\n\n\n\n\nHead of the Multiple Sclerosis Unit at the Ain Shams Specialized University Hospital  \n\n\n\n\n\n\n\n\n\n\n\n\nMelinda Magyari\n\n\n\n\nDirector of the Danish Multiple Sclerosis Registry \n\n\n\n\n\n\n\n\nTjalf Ziemssen\n\n\n\n\nProfessor of Clinical Neuroscience at University Clinic Carl-Gustav Carus in Dresden \n\n\n\n\n\n\n\n\n\n\n\n\nNikolaos Grigoriadis\n\n\n\n\nProfessor of Neurology at the Aristotle University of Thessaloniki \n\n\n\n\n\n\n\n\n\n\n\n\nJelena Drulovic\n\n\n\n\nProfessor of Neurology at the Faculty of Medicine\, University of Belgrade \n\n\n\n\n\n\n\nFunding \n\n\n\nThis webinar was organized with the financial support of Sandoz. \n\n\n\nSandoz has not been involved in the elaboration of the presentations.
URL:https://paradigms.foundation/event/how-healthcare-system-classification-impacts-treatment-choice-in-multiple-sclerosis/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/07/PMS-PROD-webinar-261029-banner-1080x655px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261123T170000
DTEND;TZID=Europe/Paris:20261123T181500
DTSTAMP:20260925T132140Z
CREATED:20260804T090238Z
LAST-MODIFIED:20260925T132140Z
UID:14645-1795453200-1795457700@paradigms.foundation
SUMMARY:Live Webinar: A Biosimilar in Multiple Sclerosis Care in Belgium: Evidence\, Confidence and Implementation
DESCRIPTION:Live webinar | Online \n\n\n\nJoin a 75-minute expert-led webinar examining the clinical\, regulatory and practical considerations involved in introducing a biosimilar into Multiple Sclerosis (MS) care in Belgium. \n\n\n\nThe programme will combine Belgian healthcare perspectives with experience from France and practical insights into MS-centre workflows. Participants will also have the opportunity to discuss implementation questions during an extended panel discussion and Q&A. \n\n\n\n\nRegister for the live webinar\n\n\n\n\nAbout the webinar\n\n\n\nWith the expected introduction of a biosimilar treatment option in Belgian MS care\, neurologists need clear and independent education on how biosimilars are assessed\, approved and implemented. \n\n\n\nThis webinar will address the regulatory principles and clinical evidence supporting biosimilars\, including how they differ from generics. It will also consider how international experience may inform decision-making in Belgium. \n\n\n\nThe faculty will discuss practical implementation in daily MS care\, including communication with people living with MS\, shared decision-making\, infusion-centre pathways\, multidisciplinary coordination and monitoring procedures. \n\n\n\nLearning objectives\n\n\n\nBy the end of the webinar\, participants will be able to: \n\n\n\n\nExplain the regulatory framework for biosimilars and how biosimilars differ from generics.\n\n\n\nRelate experience from the introduction of a biosimilar in France to the Belgian context.\n\n\n\nDiscuss practical approaches to patient communication\, infusion pathways and monitoring when implementing biosimilars in MS care.\n\n\n\nSupport informed discussion about biosimilars with multidisciplinary care teams and people living with Multiple Sclerosis.\n\n\n\nConsider the practical implications of biosimilar implementation for MS-centre workflows.\n\n\n\n\nWho should attend?\n\n\n\nThis webinar is intended for: \n\n\n\n\nClinically active neurologists based in Belgium\n\n\n\nMultiple Sclerosis specialists\n\n\n\nNeurology residents and trainees\n\n\n\nMS nurses and other healthcare professionals involved in multidisciplinary MS care\n\n\n\n\nThe webinar will be submitted for accreditation to the relevant Belgian authorities. \n\n\n\nRecording\n\n\n\nThe webinar recording is expected to be published on the ParadigMS educational platform following the live session. Access will be restricted to healthcare professionals. \n\n\n\nRegistration\n\n\n\nThis session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions!  \n\n\n\n\nRegister for the live webinar\n\n\n\n\nLanguage\n\n\n\nThe session will be held in English with translated auto-captions into many languages (offered by Zoom platform). \n\n\n\nFind out more about the speakers:\n\n\n\nProf. Bart Van Wijmeersch\n\n\n\nChair and moderator \n\n\n\nNeurologist and Medical Director at the Rehabilitation & MS Center in Pelt\, Belgium\, and Associate Professor at Hasselt University. \n\n\n\nDr Serena Borrelli\n\n\n\nSpeaker  \n\n\n\nNeurologist and Medical Doctor at Univertsité Libre de Bruxelles\, Belgium \n\n\n\nProf. Jérôme de Sèze\n\n\n\nSpeaker  \n\n\n\nNeurologist at Strasbourg University Hospitals and Head of the MS Expert Centre / CRC SEP in France. \n\n\n\nPiet Eelen\, RN\, MSc\n\n\n\nSpeaker  \n\n\n\nClinical Nurse Specialist in Multiple Sclerosis at the National MS Center in Melsbroek\, Belgium. \n\n\n\nFunding\n\n\n\nThis webinar was organized with the financial support of Sandoz. \n\n\n\nSandoz has not been involved in the elaboration of the presentations.
URL:https://paradigms.foundation/event/14645/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/08/LAU-PROD-banner-live-webinar-sessions-261123-1920x1080px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261127T123000
DTEND;TZID=Europe/Paris:20261127T190000
DTSTAMP:20261001T135410Z
CREATED:20260714T094238Z
LAST-MODIFIED:20261001T135410Z
UID:14567-1795782600-1795806000@paradigms.foundation
SUMMARY:Paradigms Regional MS Symposium
DESCRIPTION:Co-organized by the Hungarian Neuroimmunology Society and by ParadigMS Foundation\, the Symposium is specifically designed to address the clinical and educational needs of the region. \n\n\n\nThe meeting will take place in Szeged\, Hungary.\n\n\n\n\n\n\n\n\nRegister to join the IN-PERSON meeting\n\n\n\n\nMeeting details\n\n\n\nDate: Friday\, 27 November 2026Time: 12:30-18:50Location: ART Hotel\, Szeged\, 6720 Somogyi u. 16m\, Hungary \n\n\n\nOrganised by: Paradig:S and the Hungarian Neuroimmunology Society \n\n\n\nAdvances in the management of neuroimmunological diseases continue to raise new clinical questions. This regional symposium will provide an interactive forum where experts discuss real-world therapeutic challenges in Multiple Sclerosis (MS)\, Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD). Through case presentations\, panel debates and evidence-based lectures\, participants will explore practical approaches to diagnosis\, treatment optimisation and regional clinical practice. \n\n\n\nVenue\n\n\n\nART HotelSomogyi u. 16\, 6720 Szeged\, Hungary \n\n\n\n\n\n\n\nScientific committee\n\n\n\n\nCecilia Rajda\n\n\n\nMelinda Magyari\n\n\n\nGregor Brecl Jakob\n\n\n\nMario Habek\n\n\n\nRodica Balasa\n\n\n\nJelena Drulovic \n\n\n\n\nProgramme overview\n\n\n\nParadigMS Regional MS Symposium_Szeged 2026 – Programme 2809Download\n\n\n\n\n\n\n\nWhy attend?\n\n\n\nThis regional symposium offers an opportunity to engage with leading experts on current therapeutic challenges in Multiple Sclerosis (MS)\, Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD). Through debate-style sessions\, case-based learning and expert presentations\, participants will gain practical insights into treatment optimisation\, evolving diagnostic criteria\, long-term risk mitigation and region-specific approaches to patient management. \n\n\n\nOrganised by\n\n\n\n\nHungarian Neuroimmunology Society\n\n\n\nParadigms Foundation\n\n\n\n\n        \n            \n              \n                        \n                            Hungarian Neuroimmunology Society\n                        \n                    \n                        \n                            Paradigms Foundation
URL:https://paradigms.foundation/event/paradigms-regional-ms-symposium-2/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/07/PMS-PROD-Regional-Symposium-2026-banner-1080x655px-02.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261203T134500
DTEND;TZID=Europe/Paris:20261203T144500
DTSTAMP:20260922T100812Z
CREATED:20260922T100423Z
LAST-MODIFIED:20260922T100812Z
UID:14932-1796305500-1796309100@paradigms.foundation
SUMMARY:Paradigms pre-MENACTRIMS Symposium 2026
DESCRIPTION:Intercontinental Festival City\, Dubai\, United Arab Emirates \n\n\n\nAdvancing Multiple Sclerosis Care Across the Middle East and North Africa\n\n\n\nMENACTRIMS\, the Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis\, is a regional scientific organisation dedicated to advancing knowledge\, research\, education and clinical care in multiple sclerosis (MS) and related neuroimmunological disorders across the Middle East and North Africa. \n\n\n\nMENACTRIMS brings together neurologists\, researchers\, healthcare professionals and experts from across the region and internationally\, creating a platform for scientific exchange\, collaboration and education. \n\n\n\nThrough its scientific and educational activities\, MENACTRIMS aims to support healthcare professionals in navigating a rapidly evolving MS landscape and translating advances in research\, diagnosis\, monitoring and treatment into meaningful improvements in clinical practice. \n\n\n\nParadigMS Pre-MENACTRIMS Symposium\n\n\n\nFrom Biomarkers to Better Decisions in Multiple Sclerosis\n\n\n\nHeld in conjunction with MENACTRIMS\, the ParadigMS Pre-MENACTRIMS Symposium is a focused scientific and educational meeting bringing together experts in multiple sclerosis to explore how emerging tools and biomarkers can support more personalised approaches to MS management. \n\n\n\nAs the MS treatment landscape becomes increasingly complex\, clinicians have access to a growing range of information beyond conventional clinical assessment. Advanced imaging\, fluid biomarkers and digital technologies offer new possibilities for detecting disease activity\, evaluating treatment response and identifying patients who may be at greater risk of progression. \n\n\n\nThe symposium will examine how these developments can move from scientific promise towards meaningful application in everyday clinical practice. \n\n\n\nKey Takeaways\n\n\n\n\nHow technological\, imaging and fluid biomarkers may contribute to more personalised MS treatment decisions.\n\n\n\nWhich biomarker signals may help identify subclinical disease activity\, treatment response and progression risk.\n\n\n\nThe role of imaging biomarkers in monitoring inflammatory activity\, neurodegeneration and smouldering disease.\n\n\n\nHow serum neurofilament light chain and other fluid biomarkers may be interpreted in clinical practice.\n\n\n\nHow digital and wearable technologies may complement clinic-based assessment by capturing real-world function over time.\n\n\n\nThe key limitations\, confounding factors and standardisation issues affecting biomarker interpretation.\n\n\n\nHow biomarker information can be integrated with clinical judgement\, MRI findings\, patient characteristics and treatment goals.\n\n\n\nWhich biomarkers are closest to routine clinical implementation and which remain primarily investigational.\n\n\n\nHow biomarker strategies may be adapted to different healthcare systems and levels of resource availability.\n\n\n\n\nWith thanks to our sponsor\, who supports this event without any involvement in the elaboration of the presentations.
URL:https://paradigms.foundation/event/paradigms-pre-menactrims-symposium-2026/
ATTACH;FMTTYPE=image/png:https://paradigms.foundation/wp-content/uploads/2026/09/Banner-MENACTRIMS-2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261221T170000
DTEND;TZID=Europe/Paris:20261221T180000
DTSTAMP:20260922T101743Z
CREATED:20260902T100219Z
LAST-MODIFIED:20260922T101743Z
UID:14751-1797872400-1797876000@paradigms.foundation
SUMMARY:Live Webinar on the new therapies in Myasthenia Gravis
DESCRIPTION:Live webinar | Monday 21 December 2026 | 17:00–18:00 CET \n\n\n\nJoin this live ParadigMS webinar for an expert-led discussion on new and emerging therapies in myasthenia gravis\, with a focus on their relevance for clinical practice. \n\n\n\nDuring this one-hour session\, Andrew Chan\, Maura Pugliatti and Celia Oreja-Guevara will review current developments and discuss how advances in treatment may influence therapeutic decision-making. \n\n\n\nThe session will bring together leading experts to discuss current clinical considerations and provide practical insights relevant to neurologists and healthcare professionals involved in MS care. \n\n\n\nRegister to join the live webinar and hear perspectives from leading neurology experts. \n\n\n\nKey Highlights\n\n\n\nThe session will provide an expert overview of the changing treatment landscape in myasthenia gravis and its implications for clinical practice. Participants will have the opportunity to: \n\n\n\n\nExplore recent developments in therapies for myasthenia gravis.\n\n\n\nReview the evolving therapeutic landscape.\n\n\n\nConsider the clinical relevance of new treatment options.\n\n\n\nHear expert perspectives on treatment decision-making.\n\n\n\nJoin the discussion during the live session.\n\n\n\n\nMore information & Learning Objectives to come soon\n\n\n\nRegister\n\n\n\nThis session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions!  \n\n\n\nLanguage\n\n\n\nThe session will be held in English with translated auto-captions into many languages (offered by Zoom platform). \n\n\n\nWho should attend?\n\n\n\n\nNeurologists and paediatric neurologists with an interest in Multiple Sclerosis\n\n\n\nMS specialists and neurologists in training\n\n\n\nNurses and other healthcare professionals involved in MS care\n\n\n\nHealthcare professionals involved in the diagnosis or management of paediatric demyelinating disorders\n\n\n\n\nQuestions and comments\n\n\n\nShould you have specific questions\, you would like to see discussed\, please share them with learning@paradigms.foundation now\, so the speakers could relate to them in their presentations.  \n\n\n\nYou will also have the opportunity to ask questions in person and participate in discussion during the webinar and the Q&A session. \n\n\n\nTechnology used\n\n\n\nThe webinar takes place via Zoom\, you will receive connection details upon registration. \n\n\n\nDate and time\n\n\n\nDate: Monday 21 December 2026Time: 17:00-18:00 CETFormat: Live online webinarDuration: 60 minutes \n\n\n\nSpeakers\n\n\n\nFind out more about the speakers: \n\n\n\n\n\n\n\nCelia Oreja-Guevara \n\n\n\nVice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos\, Madrid \n\n\n\n\n\n\n\nAndrew Chan \n\n\n\nHead of the Medical Division Neuro at the Bern University Hospital \n\n\n\n\n\n\n\nMaura Pugliatti \n\n\n\nProfessor of Neurology at the University of Ferrara \n\n\n\nFunding\n\n\n\nThis webinar is funded with ParadigMS own funds. No other sponsors have been invited to support this webinar.
URL:https://paradigms.foundation/event/new-therapies-in-myasthenia-gravis/
ATTACH;FMTTYPE=image/png:https://paradigms.foundation/wp-content/uploads/2026/09/New-therapies-in-MG.png
END:VEVENT
END:VCALENDAR